Long-term use of a left ventricular assist device for end-stage heart failure - The New England Journal of Medicine - 2001
Brief Summary:
In patients with end-stage heart failure, destination left ventricular assist device (LVAD) therapy reduces all-cause mortality, as compared to optimal medical therapy.Reference: http://www.ncbi.nlm.nih.gov/pubmed/11794191
Comments
Post a Comment
Drop your thoughts here, we would love to hear from you